Publisher
Springer International Publishing
Reference72 articles.
1. Aleman A, Kahn RS. Effects of the antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials. Eur Neuropsychopharmacol. 2001;11:289–93.
2. Ascher-Svanum H, Nyhuis AW, Faries DE, Ball DE, Kinon BJ. Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia. BMC Psychiatry. 2010;10:11.
3. Barratt ES, Stanford MS, Kent TA, Felthous A. Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biol Psychiatry. 1997;41:1045–61.
4. Baruch N, Das M, Sharda A, Basu A, Bajorek T, Ross CC, Sengupta S, Young S. An evaluation of the use of olanzapine pamoate depot injection in seriously violent men with schizophrenia in an UK high-security hospital. Ther Adv Psychopharmacol. 2014;4:186–92.
5. Beck NC, Greenfield SR, Gotham H, Menditto AA, Stuve P, Hemme CA. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility. J Am Acad Psychiatry Law. 1997;25:461–8.